Resources
6 Results (showing 1 - 6)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 12/24/2020 (updated 4/4/2024)
The Townhall TeleECHO presentation will introduce a monthly interactive opportunity for clinicians and their support staff to address challenges and share solutions and successes to gain confidence in addressing OUD with MOUD. The Behavioral Health Data Learning Collaborative presentation will introduce goals of understanding data and data sharing, use of indicators and data sources, and data driven programming and quality improvement. Open discussion will follow each presentation.
Posted 10/23/2020 (updated 4/3/2024)
These pilot study results suggest comparable safety and effectiveness of unobserved and office induction and point toward utilization of non-inferiority design during future definitive protocol development.
Posted 10/23/2020 (updated 4/3/2024)
This article offers data regarding offering buprenorphine treatment at a public hospital primary care setting using a home, unobserved induction protocol.
Posted 1/24/2020 (updated 3/28/2024)
Get Naloxone Now is an online resource to train people to respond effectively to an opioid overdose emergency.
Posted 11/21/2019 (updated 3/28/2024)
This guide provides a brief overview on identifying potential patients and introducing them to the program, as well as an overview of the medical-management counseling process.
Posted 3/14/2023 (updated 3/27/2024)
Xylazine is a non-opioid that is approved for animals, and not FDA-approved for humans. New York State's Department of Health provides information on what it is, sources and trends, effects, why people use it, why clinicians should be concerned, and other information on Xylazine. Information about Xylazine is important to understand now that it has been showing up in illicit drug supply.